Health OSdemo workspace
Employer

Pinecrest Foodsactive

Internal only · as of Oct 14
Period member reach
100%
16 distinct people100.0% long-term
Jul 2026 reach
100%
7 of 7 covered+0 pp vs Jun 2026
Care delivered
96
10.7 visits / month16 people
Preventive share
28%
27 preventive visits46% acute
Known risk signal
31%
5 of 16 adults2 higher severity
Reporting periodNov 2025 – Jul 20269 months
Change period
Visits through Jul 31, 2026 · measures through Jul 28, 2026

Population

covered lives and relationship mix
Covered lives by month
1003Nov '254Dec '254Jan '265Feb '265Mar '266Apr '266May '267Jun '267Jul '26
employeesspouses and children
Jul 2026 mix7 covered lives
Employees6 86%
Spouses1 14%
Children0 0%
Care delivered
Monthly member reach
100%0%Nov 2025: 100% reach · 3 of 3 covered lives seenNov '25Dec 2025: 100% reach · 4 of 4 covered lives seenDec '25Jan 2026: 100% reach · 4 of 4 covered lives seenJan '26Feb 2026: 100% reach · 5 of 5 covered lives seenFeb '26Mar 2026: 100% reach · 5 of 5 covered lives seenMar '26Apr 2026: 100% reach · 6 of 6 covered lives seenApr '26May 2026: 100% reach · 6 of 6 covered lives seenMay '26Jun 2026: 100% reach · 7 of 7 covered lives seenJun '26Jul 2026: 100% reach · 7 of 7 covered lives seenJul '26100%100%100%100%100%100%100%100%100%
member reach · people seen ÷ covered lives that month
Clinical activityvisit-type evidence · 96 visits
Preventive27 28%
Acute44 46%
Health review18 19%
Other7 7%
Delivery87 in person9 virtual

Clinical risk burden

Known clinical signals across the covered adult population.

16 adults

Population burden

40 dots · Each ≈ 2.5% of covered adults

Higher severity
2 12.5%
Included in elevated signal
Elevated signal
5 31.3%
Moderate + higher severity
Assessed
11 68.8%
Adults with scoreable evidence
Unknown
5 31.3%
Includes unmeasured results
Higher severityModerateNo elevated signal observedUnknown / unmeasured
Risk by clinical domainThrough Jul 31, 2026 · 24-month lookback
Ranked by higher-severity count

Metabolic

11 of 16 assessed · 68.8% coverage

31.3% moderate or higher

5 adults · 2 higher severity

Higher severity
12.5%
Moderate
18.8%
No elevation
37.5%
Unknown
31.3%

All percentages use covered adults. Population burden counts each adult once; clinical domains overlap. No elevation means no elevated signal observed.

Risk concentrationAdults by number of known affected clinical domains
Known burden; no minimum-evidence gate
Unknown5 31%
0 known affected domains6 38%
1 affected domain5 31%
2 affected domains0 0%
3+ affected domains0 0%
Common overlapping domainsAdults with known elevated evidence in both domains

No multi-domain overlap is visible in current scoreable evidence.

Core indicator detailSingle-measure context; not complete clinical domains
Blood pressureSystolic proxy · 124 mmHg avg44% 7 of 16
Weight / metabolicBMI proxy · 27.1 kg/m² avg44% 7 of 16
Glycemic / insulinA1C proxy · 5.8% avg44% 7 of 16
Lipid / vascularLDL proxy · 119.0 mg/dL avg44% 7 of 16

Risk uses each marker’s latest scoreable result on or before the report end date, up to 24 months old. Unit-missing values never enter numeric model bands; exact source high/low flags contribute a moderate known signal. Any known elevated result counts immediately; missing evidence remains unknown.

Monthly detail

the underlying ledger
MonthCovered livesemployees · spouses · childrenJoined / leftVisitsPeople seenMember reachPreventiveAcuteHealth reviewOtherIn personVirtual
Nov 202532 · 1 · 0+1 −083100%242071
Dec 202543 · 1 · 0+1 −094100%242181
Jan 202643 · 1 · 0+0 −0114100%3521101
Feb 202654 · 1 · 0+1 −0105100%342191
Mar 202654 · 1 · 0+0 −0125100%3621111
Apr 202665 · 1 · 0+1 −0136100%4621121
May 202665 · 1 · 0+0 −0116100%3521101
Jun 202676 · 1 · 0+1 −0107100%352091
Jul 202676 · 1 · 0+0 −1127100%4521111
Period5monthly average · 3–7+5 −19616distinct100%of 5.2 average enrollment2744187879
9 of 9 months contain observed encounters